ARCHIVES

New Drugs Improve Outlook For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

NCI Cooperative Group, Cancer Center Trials Listed

January 25, 2008

Limb-Sparing Surgery May Not Offer Better Quality of Life

August 28, 2009

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004